Recap: Coherus BioSciences Q1 Earnings

Coherus BioSciences CHRS reported its Q1 earnings results on Thursday, May 5, 2022 at 05:01 PM.

Here's what investors need to know about the announcement.

Coherus BioSciences missed estimated earnings by 108.33%, reporting an EPS of $-1.0 versus an estimate of $-0.48.

Revenue was down $22.92 million from the same period last year.

Last quarter the company beat on EPS by $0.05 which was followed by a 4.12% drop in the share price the next day.

Here's a look at Coherus BioSciences's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.51	-0.22	-0.17	0.06
EPS Actual	-0.46	-0.34	-0.36	0.01
Revenue Estimate	85.81M	91.31M	89.81M	96.00M
Revenue Actual	73.37M	82.50M	87.64M	83.03M

To track all earnings releases for Coherus BioSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar